174 related articles for article (PubMed ID: 1732426)
1. Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: a Pediatric Oncology Group randomized phase II study.
Friedman HS; Krischer JP; Burger P; Oakes WJ; Hockenberger B; Weiner MD; Falletta JM; Norris D; Ragab AH; Mahoney DH
J Clin Oncol; 1992 Feb; 10(2):249-56. PubMed ID: 1732426
[TBL] [Abstract][Full Text] [Related]
2. Activity and toxicity of carboplatin and iproplatin in relapsed high-grade glioma.
Twelves CJ; Ash CM; Miles DW; Thomas DG; Souhami RL
Cancer Chemother Pharmacol; 1991; 27(6):481-3. PubMed ID: 2013119
[TBL] [Abstract][Full Text] [Related]
3. Randomized phase II trial of iproplatin and carboplatin in advanced breast cancer. The EORTC Early Clinical Trials Group and the EORTC Data Center.
Vermorken JB; Gundersen S; Clavel M; Smyth JF; Dodion P; Renard J; Kaye SB
Ann Oncol; 1993 Apr; 4(4):303-6. PubMed ID: 8518220
[TBL] [Abstract][Full Text] [Related]
4. A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group study.
McGuire WP; Arseneau J; Blessing JA; DiSaia PJ; Hatch KD; Given FT; Teng NN; Creasman WT
J Clin Oncol; 1989 Oct; 7(10):1462-8. PubMed ID: 2674333
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of carboplatin in children with progressive low-grade gliomas.
Gururangan S; Cavazos CM; Ashley D; Herndon JE; Bruggers CS; Moghrabi A; Scarcella DL; Watral M; Tourt-Uhlig S; Reardon D; Friedman HS
J Clin Oncol; 2002 Jul; 20(13):2951-8. PubMed ID: 12089224
[TBL] [Abstract][Full Text] [Related]
6. Phase II investigational window using carboplatin, iproplatin, ifosfamide, and epirubicin in children with untreated disseminated neuroblastoma: a Pediatric Oncology Group study.
Castleberry RP; Cantor AB; Green AA; Joshi V; Berkow RL; Buchanan GR; Leventhal B; Mahoney DH; Smith EI; Hayes FA
J Clin Oncol; 1994 Aug; 12(8):1616-20. PubMed ID: 8040674
[TBL] [Abstract][Full Text] [Related]
7. Second-line treatment of advanced measurable ovarian cancer with iproplatin: a Southwest Oncology Group study.
Weiss G; Green S; Alberts DS; Thigpen JT; Hines HE; Hanson K; Pierce HI; Baker LH; Goodwin JW
Eur J Cancer; 1991; 27(2):135-8. PubMed ID: 1827275
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial of carboplatin or iproplatin in cervical cancer.
Lira-Puerto V; Silva A; Morris M; Martinez R; Groshen S; Morales-Canfield F; Tenorio F; Muggia F
Cancer Chemother Pharmacol; 1991; 28(5):391-6. PubMed ID: 1914084
[TBL] [Abstract][Full Text] [Related]
9. Carboplatin and recurrent childhood brain tumors.
Allen JC; Walker R; Luks E; Jennings M; Barfoot S; Tan C
J Clin Oncol; 1987 Mar; 5(3):459-63. PubMed ID: 3546620
[TBL] [Abstract][Full Text] [Related]
10. Randomised phase II trial of carboplatin and iproplatin in advanced urothelial cancer.
de Wit R; Tesselaar M; Kok TC; Seynaeve C; Rodenburg CJ; Verweij J; Helle PA; Stoter G
Eur J Cancer; 1991; 27(11):1383-5. PubMed ID: 1835851
[TBL] [Abstract][Full Text] [Related]
11. Iproplatin and carboplatin induced toxicities: overview of phase II clinical trial conducted by the EORTC Early Clinical Trials Cooperative Group (ECTG).
van Glabbeke M; Renard J; Pinedo HM; Cavalli F; Vermorken J; Sessa C; Abele R; Clavel M; Monfardini S
Eur J Cancer Clin Oncol; 1988 Feb; 24(2):255-62. PubMed ID: 3281842
[TBL] [Abstract][Full Text] [Related]
12. Carboplatin is effective therapy for young children with progressive optic pathway tumors: a Pediatric Oncology Group phase II study.
Mahoney DH; Cohen ME; Friedman HS; Kepner JL; Gemer L; Langston JW; James HE; Duffner PK; Kun LE
Neuro Oncol; 2000 Oct; 2(4):213-20. PubMed ID: 11265230
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial of carboplatin versus iproplatin in untreated advanced ovarian cancer.
Trask C; Silverstone A; Ash CM; Earl H; Irwin C; Bakker A; Tobias JS; Souhami RL
J Clin Oncol; 1991 Jul; 9(7):1131-7. PubMed ID: 2045855
[TBL] [Abstract][Full Text] [Related]
14. Phase I trial of carboplatin-cyclophosphamide and iproplatin-cyclophosphamide in advanced ovarian cancer: a Southwest Oncology Group study.
Alberts D; Mason N; Surwit E; Weiner S; Hammond N; Deppe G
Cancer Treat Rev; 1985 Sep; 12 Suppl A():83-92. PubMed ID: 3910225
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of intravenous lobradimil and carboplatin in childhood brain tumors: a report from the Children's Oncology Group.
Warren K; Jakacki R; Widemann B; Aikin A; Libucha M; Packer R; Vezina G; Reaman G; Shaw D; Krailo M; Osborne C; Cehelsky J; Caldwell D; Stanwood J; Steinberg SM; Balis FM
Cancer Chemother Pharmacol; 2006 Sep; 58(3):343-7. PubMed ID: 16408203
[TBL] [Abstract][Full Text] [Related]
16. Carboplatin hypersensitivity reaction in pediatric patients with low-grade glioma: a Canadian Pediatric Brain Tumor Consortium experience.
Lafay-Cousin L; Sung L; Carret AS; Hukin J; Wilson B; Johnston DL; Zelcer S; Silva M; Odame I; Mpofu C; Strother D; Bouffet E
Cancer; 2008 Feb; 112(4):892-9. PubMed ID: 18098210
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of CHIP (iproplatin) in recurrent pediatric malignant solid tumors. A phase II study (Pediatric Oncology Group).
Nitschke R; Pratt C; Harris M; Krischer J; Vietti TJ; Grier H; Kamps W; Toledano S
Invest New Drugs; 1992 Jul; 10(2):93-6. PubMed ID: 1323551
[TBL] [Abstract][Full Text] [Related]
18. Pediatric phase I trial of carboplatin: a Childrens Cancer Study Group report.
Gaynon PS; Ettinger LJ; Moel D; Siegel SE; Baum ES; Krivit W; Hammond GD
Cancer Treat Rep; 1987 Nov; 71(11):1039-42. PubMed ID: 3315195
[TBL] [Abstract][Full Text] [Related]
19. A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroectodermal tumor, or brainstem glioma: a Children's Oncology Group study.
Fouladi M; Nicholson HS; Zhou T; Laningham F; Helton KJ; Holmes E; Cohen K; Speights RA; Wright J; Pollack IF;
Cancer; 2007 Dec; 110(11):2535-41. PubMed ID: 17932894
[TBL] [Abstract][Full Text] [Related]
20. Phase I study of carboplatin (CBDCA) in children with cancer.
Bacha DM; Caparros-Sison B; Allen JA; Walker R; Tan CT
Cancer Treat Rep; 1986 Jul; 70(7):865-9. PubMed ID: 3521846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
